310 related articles for article (PubMed ID: 18819179)
1. Elimination of menstrual-related migraine beneficially impacts chronification and medication overuse.
Calhoun A; Ford S
Headache; 2008 Sep; 48(8):1186-93. PubMed ID: 18819179
[TBL] [Abstract][Full Text] [Related]
2. Hormonal therapies for menstrual migraine.
Calhoun AH; Hutchinson S
Curr Pain Headache Rep; 2009 Oct; 13(5):381-5. PubMed ID: 19728965
[TBL] [Abstract][Full Text] [Related]
3. Comparing Perimenstrual and Nonperimenstrual Migraine Attacks Using an e-Diary.
van Casteren DS; Verhagen IE; van der Arend BWH; van Zwet EW; MaassenVanDenBrink A; Terwindt GM
Neurology; 2021 Oct; 97(17):e1661-e1671. PubMed ID: 34493613
[TBL] [Abstract][Full Text] [Related]
4. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
[TBL] [Abstract][Full Text] [Related]
5. [Clinical features and mechanisms of chronic migraine and medication-overuse headache].
Takeshima T
Rinsho Shinkeigaku; 2010 Nov; 50(11):990-3. PubMed ID: 21921539
[TBL] [Abstract][Full Text] [Related]
6. Diagnosis of menstrual headache and an open-label study among those with previously undiagnosed menstrually related migraine to evaluate the efficacy of sumatriptan 100 mg.
Schreiber CP; Cady RK
Clin Ther; 2007; 29 Suppl():2511-9. PubMed ID: 18164918
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of migraine attacks and responses to almotriptan treatment: a comparison of menstrually related and nonmenstrually related migraines.
Diamond ML; Cady RK; Mao L; Biondi DM; Finlayson G; Greenberg SJ; Wright P
Headache; 2008 Feb; 48(2):248-58. PubMed ID: 18234046
[TBL] [Abstract][Full Text] [Related]
8. Temporal relations in hormone-withdrawal migraines and impact on prevention- a diary-based pilot study in combined hormonal contraceptive users.
Merki-Feld GS; Epple G; Caveng N; Imthurn B; Seifert B; Sandor P; Gantenbein AR
J Headache Pain; 2017 Aug; 18(1):91. PubMed ID: 28842849
[TBL] [Abstract][Full Text] [Related]
9. SumaRT/Nap vs naproxen sodium in treatment and disease modification of migraine: a pilot study.
Cady R; O'Carroll P; Dexter K; Freitag F; Shade CL
Headache; 2014 Jan; 54(1):67-79. PubMed ID: 24021029
[TBL] [Abstract][Full Text] [Related]
10. Unsatisfactory response to acute medications does not affect the medication overuse headache development in pediatric chronic migraine.
Frattale I; Ferilli MAN; Ursitti F; Sforza G; Monte G; Proietti Checchi M; Tarantino S; Mazzone L; Valeriani M; Papetti L
J Headache Pain; 2024 Apr; 25(1):61. PubMed ID: 38649822
[TBL] [Abstract][Full Text] [Related]
11. Adding Additional Acute Medications to a Triptan Regimen for Migraine and Observed Changes in Headache-Related Disability: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Buse DC; Serrano D; Reed ML; Kori SH; Cunanan CM; Adams AM; Lipton RB
Headache; 2015 Jun; 55(6):825-39. PubMed ID: 25881857
[TBL] [Abstract][Full Text] [Related]
12. Headache characteristics and burden from chronic migraine with medication overuse headache: Cross-sectional observations from the Medication Overuse Treatment Strategy trial.
Schwedt TJ; Hentz JG; Sahai-Srivastava S; Spare NM; Martin VT; Treppendahl C; Digre K; Bennett NL; Birlea M; Watson D; Murinova N; Robert T; Dodick DW;
Headache; 2021 Feb; 61(2):351-362. PubMed ID: 33432635
[TBL] [Abstract][Full Text] [Related]
13. Analysis of leukocytes in medication-overuse headache, chronic migraine, and episodic migraine.
Forcelini CM; Dantas DC; Luz C; Santin R; Stein AT; Barros HM; Barea LM
Headache; 2011 Sep; 51(8):1228-38. PubMed ID: 21649652
[TBL] [Abstract][Full Text] [Related]
14. Obsessive-compulsive disorder and migraine with medication-overuse headache.
Cupini LM; De Murtas M; Costa C; Mancini M; Eusebi P; Sarchielli P; Calabresi P
Headache; 2009 Jul; 49(7):1005-13. PubMed ID: 19496831
[TBL] [Abstract][Full Text] [Related]
15. Evidences of Reduced Antioxidant Activity in Patients With Chronic Migraine and Medication-Overuse Headache.
Lucchesi C; Baldacci F; Cafalli M; Chico L; Lo Gerfo A; Bonuccelli U; Siciliano G; Gori S
Headache; 2015; 55(7):984-91. PubMed ID: 26129705
[TBL] [Abstract][Full Text] [Related]
16. Open-label, long-term tolerability of naratriptan for short-term prevention of menstrually related migraine.
Brandes JL; Smith T; Diamond M; Ames MH
Headache; 2007 Jun; 47(6):886-94. PubMed ID: 17578540
[TBL] [Abstract][Full Text] [Related]
17. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of naratriptan for short-term prevention of menstrually related migraine: data from two randomized, double-blind, placebo-controlled studies.
Mannix LK; Savani N; Landy S; Valade D; Shackelford S; Ames MH; Jones MW
Headache; 2007; 47(7):1037-49. PubMed ID: 17635595
[TBL] [Abstract][Full Text] [Related]
19. Is iron deficiency anemia related to menstrual migraine? Post hoc analysis of an observational study evaluating clinical characteristics of patients with menstrual migraine.
Vuković-Cvetković V; Plavec D; Lovrencić-Huzjan A; Galinović I; Serić V; Demarin V
Acta Clin Croat; 2010 Dec; 49(4):389-94. PubMed ID: 21830449
[TBL] [Abstract][Full Text] [Related]
20. A novel specific prophylaxis for menstrual-associated migraine.
Calhoun AH
South Med J; 2004 Sep; 97(9):819-22. PubMed ID: 15455962
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
